Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol Medicaid subpoena

Executive Summary

Bristol-Myers Squibb "best price" reporting requirements under Medicaid are the subject of a subpoena from Massachusetts U.S. Attorney's Office, company says in Securities & Exchange Commission filing Aug. 8. Bristol recently commenced an "internal review" to determine whether Medicaid rebates and pricing practices have been appropriate (1"The Pink Sheet" July 28, 2003, p. 33). Bristol met with Boston U.S. Attorney's Office to "discuss the review and its plan for sharing the results of the review," filing says. The company "subsequently received a subpoena...relating to the subject matter of the review"...
Advertisement

Related Content

Bristol Earnings Feature Downside Disclosures But Still Rely On Restructuring
Bristol Earnings Feature Downside Disclosures But Still Rely On Restructuring
Advertisement
UsernamePublicRestriction

Register

PS042312

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel